Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 2.080
-0.030 (-1.42%)
Sep 12, 2025, 3:45 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 1.50 billion as of September 12, 2025. Its market cap has increased by 113.53% in one year.
Market Cap
1.50B
Enterprise Value
-825.26M
Revenue
31.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.08
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 1.50B, a decrease of -90.77%. That is a compound annual growth rate of -43.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.50B | 108.84% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | 16.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.07B |
| Hansoh Pharmaceutical Group Company | 233.56B |
| JD Health International | 220.26B |
| Innovent Biologics | 166.31B |
| Sino Biopharmaceutical | 150.95B |
| WuXi Biologics | 146.30B |
| Akeso | 122.97B |
| CSPC Pharmaceutical Group | 115.70B |